Cite
MLA Citation
Aric Parnes et al.. “Patient preference for emicizumab versus prior factor therapy in people with haemophilia A: Results from the HAVEN 3 and HAVEN 4 studies.” Haemophilia, vol. 27, no. 6, 2021, pp. e772–e775. http://access.bl.uk/ark:/81055/vdc_100146334969.0x000035